P1121: TAKEAIM LYMPHOMA- AN OPEN-LABEL, DOSE ESCALATION AND EXPANSION TRIAL OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOG...

por Joffe, E., Nowakowski, G., Tun, H., Rosenthal, A., Lunning, M., Ramchandren, R., Li, C.-C., Zhou, L., Martinez, E., von Roemeling, R., Earhart, R., McMahon, M., Isufi, I., Leslie, L.
Publicado 2022

P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

por Cheah, C. Y., Bartlett, N. L., Assouline, S., Schuster, S. J., Seog Kim, W., Shadman, M., Isufi, I., Yin, S., Doral, M. Y., Sit, J., Chen, V., Huang, H., Zhou, M., Wei, M. C., Budde, L. E.
Publicado 2022